Asset Details
Do you wish to reserve the book?
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Do you wish to request the book?
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
2015
Overview
Genetic deletion of two fatty acid receptors in beta cells improves insulin secretion and diabetes.
Type 2 diabetes is a major health problem worldwide, and one of its key features is the inability of elevated glucose to stimulate the release of sufficient amounts of insulin from pancreatic beta cells to maintain normal blood glucose levels
1
,
2
. New therapeutic strategies to improve beta cell function are therefore believed to be beneficial
3
,
4
. Here we demonstrate that the short-chain fatty acid receptors FFA2 (encoded by
FFAR2
) and FFA3 (encoded by
FFAR3
) are expressed in mouse and human pancreatic beta cells and mediate an inhibition of insulin secretion by coupling to G
i
-type G proteins. We also provide evidence that mice with dietary-induced obesity and type 2 diabetes, as compared to non-obese control mice, have increased local formation by pancreatic islets of acetate, an endogenous agonist of FFA2 and FFA3, as well as increased systemic levels. This elevation may contribute to the insufficient capacity of beta cells to respond to hyperglycemia in obese states. Indeed, we found that genetic deletion of both receptors, either on the whole-body level or specifically in pancreatic beta cells, leads to greater insulin secretion and a profound improvement of glucose tolerance when mice are on a high-fat diet compared to controls. On the other hand, deletion of
Ffar2
and
Ffar3
in intestinal cells did not alter glucose tolerance in diabetic animals, suggesting these receptors act in a cell-autonomous manner in beta cells to regulate insulin secretion. In summary, under diabetic conditions elevated acetate acts on FFA2 and FFA3 to inhibit proper glucose-stimulated insulin secretion, and we expect antagonists of FFA2 and FFA3 to improve insulin secretion in type 2 diabetes.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ 13/1
/ 13/106
/ 13/44
/ 13/51
/ 13/89
/ 13/95
/ 64
/ 64/60
/ 692/163
/ 82
/ 82/51
/ 96
/ 96/95
/ Animals
/ Biomedical and Life Sciences
/ Blood
/ Diabetes
/ Diabetes Mellitus, Type 2 - metabolism
/ Glucose
/ Humans
/ Insulin
/ Insulin-Secreting Cells - metabolism
/ letter
/ Mice
/ Proteins
/ Receptors, Cell Surface - metabolism
/ Receptors, G-Protein-Coupled - metabolism
/ Rodents
